BioSpace News Archive

Abattis Bioceuticals Corp is pleased to announce it has entered into a non-binding letter of intent with Canadian Artesian Ice Ltd to provide Canadian Artesian with, THC- and pesticide-free cannabidiol isolate, research and development services, nanoencapsulation and nanoemulsification services, analytical and regulatory services and access to Abattis’s distribution and marketing channels to support the development, scalability and commercialization of a CBD-infused water for Canadian Artesian.

The agreement covers individual patient expanded access for AmpliPhi’s investigational bacteriophage therapeutics AB-SA01, targeting Staphylococcus aureus, and AB-PA01, targeting Pseudomonas aeruginosa.

TIME-2b Clinical Trial of AKB-9778 in patients with diabetic retinopathy remains on track

In a new story for Inside Science News Service, Joel Shurkin offers an intimate look at why Alzheimer’s research is failing to help patients, including his own wife.

Regeneron Pharmaceuticals, Inc. and Society for Science & the Public today announced that Benjamin “Benjy” Firester, 18, of New York City, won the top award in the Regeneron Science Talent Search 2018.

Calyxt Inc. announced its results for the three-month period ended December 31, 2017 and for the year ended December 31, 2017.

ASC Biosciences, Inc. is pleased to announce its first television commercial is scheduled to be aired nationally on Thursday, March 15, 2018 and Sunday, March 18, 2018 in prime time on Fox Business Network.

On Friday March 9, 2018, a press conference was held where Dr. Douglas Kalman PhD, RD, FACN, FISSN and the UFC’s Featherweight fighter Chas Skelly met the press to reveal the results of a new study that demonstrated that Axiom Foods’ Oryzatein® brown rice protein equals animal-based whey protein for building and maintaining muscle.

SCYNEXIS, Inc. reported financial results for the year ended December 31, 2017, and provided an update on recent operational and clinical developments.

Aratana Therapeutics Inc. announced its fourth quarter and full year 2017 financial results.